|Description||Genome Analysis Platform|
|Series A, 1/2014 |
Acadia Woods Partners
Bay City Capital
Omicia is unlocking individualized medicine by translating data derived from whole-genome sequencing into actionable information for researchers and clinicians. The company maintains a comprehensive database of information about genetic variations related to health conditions and is pioneering new informatics approaches that enhance the power of predictive and preventive medicine.